Trial intelligence / Profile preview

Impact of RYGB Surgery on Simvastatin and Carvedilol PK

NCT04049786Phase 4Unknown

Start
Jun 2019
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of simvastatin, carvedilol in hypercholesterolemia, hypertension (HTN). Status: unknown.

02

Drugs

simvastatincarvedilol
03

Conditions

hypercholesterolemiahypertension (HTN)

Beyond the preview

Go deeper on NCT04049786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04049786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call